Jennifer Yoon Lee, MD
Otolaryngology · Redwood City
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 5
- 2 carriers
- Offices
- 3
Offices
3 locations · Stanford Health Care · 3,152 clinicians in this group
Looking this up.
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
5 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Lee’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
5 of 5 plans
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A125587 · Current
Licensed to practise in California · since 2013 · expires 2028-07-31 · Albert Einstein College of Medicine of Yeshiva University.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$47,763
Medicare paid this office $47,763 for 204 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 49 | $4,655 | $86 |
| Diagnostic exam of nasal passages using an endoscope | 62 | $4,094 | $55 |
| Short return visit (20+ min) | 39 | $2,382 | $55 |
| New patient visit (30+ min) | 34 | $2,344 | $69 |
| Long return visit (40+ min) | 15 | $1,763 | $118 |
See all 12 services
| Return visit (30+ min) | 49 | $4,655 | $86 |
| Diagnostic exam of nasal passages using an endoscope | 62 | $4,094 | $55 |
| Short return visit (20+ min) | 39 | $2,382 | $55 |
| New patient visit (30+ min) | 34 | $2,344 | $69 |
| Long return visit (40+ min) | 15 | $1,763 | $118 |
| Long return visit (40+ min) | 11 | $1,723 | $157 |
| Diagnostic exam of nasal passages using an endoscope | 14 | $1,692 | $121 |
| Short return visit (20+ min) | 18 | $1,414 | $79 |
| Diagnostic exam of voice box using a flexible endoscope | 19 | $1,395 | $61 |
| Return visit (30+ min) | 13 | $1,388 | $107 |
| New patient visit (45+ min) | 11 | $1,318 | $120 |
| Short return visit | 30 | $1,011 | $28 |
Who their Medicare patients are
204 Original Medicare patients in 2024. Average age 73 · Under 65 11% · 85 and older 11% · Women 59% · Also on Medicaid 20% · Health risk score 1.41. Above the middle of the specialty; the typical otolaryngology clinician is at 1.19.
Conditions among them: High blood pressure 62% · Diabetes 29% · Coronary heart disease 22% · Chronic kidney disease 22% · Cancer 19% · Depression 18% · Atrial fibrillation 16% · COPD 15% · Heart failure 9% · Stroke 9% · Dementia 6%.
The office billed $294,178, Medicare allowed $61,865 and paid $47,763; for 465 services of 50 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 204 | 465 | 73 | 1.41 | $294,178 | $47,763 |
| 2023 | 231 | 545 | 72 | 1.32 | $294,863 | $52,467 |
| 2022 | 240 | 508 | 72 | 1.39 | $253,040 | $44,527 |
| 2021 | 194 | 473 | 71 | 1.30 | $247,826 | $51,836 |
| 2020 | 188 | 454 | 71 | 1.47 | $236,132 | $32,365 |
| 2019 | 143 | 323 | 71 | 1.40 | $167,490 | $24,930 |
| 2018 | 199 | 465 | 71 | 1.22 | $300,610 | $39,728 |
| 2017 | 184 | 416 | 70 | 1.36 | $319,922 | $38,537 |
| 2016 | 206 | 482 | 70 | 1.41 | $282,437 | $38,390 |
| 2015 | 273 | 679 | 71 | 1.21 | $347,094 | $52,912 |
| 2014 | 286 | 623 | 72 | 1.30 | $247,234 | $45,913 |
| 2013 | 74 | 172 | 72 | 1.39 | $36,544 | $10,984 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 9 services
| Long return visit (40+ min) | 39 | $5,585 | $133 |
| Return visit (30+ min) | 51 | $5,001 | $88 |
| Short return visit (20+ min) | 55 | $4,001 | $56 |
| Diagnostic exam of nasal passages using an endoscope | 80 | $3,785 | $37 |
| New patient visit (30+ min) | 49 | $3,636 | $74 |
| New patient visit (45+ min) | 26 | $3,188 | $123 |
| Diagnostic exam of voice box using a flexible endoscope | 33 | $2,261 | $61 |
| Short return visit | 25 | $915 | $32 |
| New patient visit (15+ min) | 14 | $551 | $39 |
2022: 10 services
| Long return visit (40+ min) | 42 | $5,854 | $122 |
| Return visit (30+ min) | 47 | $4,643 | $88 |
| New patient visit (45+ min) | 33 | $3,575 | $108 |
| Short return visit (20+ min) | 62 | $3,558 | $52 |
| New patient visit (30+ min) | 41 | $2,814 | $69 |
| Diagnostic exam of nasal passages using an endoscope | 71 | $2,026 | $24 |
| Diagnostic exam of voice box using a flexible endoscope | 29 | $1,782 | $59 |
| New patient visit (15+ min) | 20 | $632 | $32 |
| Short return visit | 20 | $627 | $31 |
| Removal of impacted ear wax | 11 | $298 | $25 |
2021: 8 services
| Long return visit (40+ min) | 68 | $11,760 | $126 |
| Return visit (30+ min) | 45 | $4,793 | $87 |
| New patient visit (60+ min) | 26 | $4,373 | $168 |
| New patient visit (45+ min) | 27 | $3,357 | $124 |
| Short return visit (20+ min) | 30 | $1,959 | $56 |
| Diagnostic exam of nasal passages using an endoscope | 68 | $1,867 | $22 |
| New patient visit (30+ min) | 26 | $1,799 | $69 |
| Diagnostic exam of voice box using a flexible endoscope | 21 | $1,516 | $63 |
2020: 6 services
| Short return visit (20+ min) | 89 | $4,974 | $40 |
| New patient visit (30+ min) | 49 | $3,252 | $66 |
| Return visit (30+ min) | 24 | $1,938 | $69 |
| New patient visit (45+ min) | 17 | $1,858 | $109 |
| Diagnostic exam of voice box using a flexible endoscope | 22 | $1,531 | $59 |
| Diagnostic exam of nasal passages using an endoscope | 71 | $1,523 | $18 |
2019: 5 services
| Short return visit (20+ min) | 67 | $3,722 | $41 |
| Diagnostic exam of nasal passages using an endoscope | 51 | $3,139 | $51 |
| New patient visit (30+ min) | 43 | $2,541 | $59 |
| Return visit (30+ min) | 26 | $1,722 | $66 |
| Diagnostic exam of voice box using a flexible endoscope | 19 | $1,068 | $53 |
2018: 5 services
| New patient visit (30+ min) | 79 | $5,100 | $65 |
| Short return visit (20+ min) | 85 | $4,884 | $41 |
| Diagnostic exam of nasal passages using an endoscope | 68 | $4,541 | $54 |
| Diagnostic exam of voice box using a flexible endoscope | 40 | $2,584 | $57 |
| Return visit (30+ min) | 28 | $1,978 | $71 |
2017: 6 services
| New patient visit (30+ min) | 65 | $4,413 | $68 |
| Diagnostic exam of nasal passages using an endoscope | 61 | $4,362 | $57 |
| Short return visit (20+ min) | 74 | $4,290 | $45 |
| Return visit (30+ min) | 42 | $2,963 | $71 |
| Diagnostic exam of voice box using a flexible endoscope | 39 | $2,330 | $60 |
| New patient visit (45+ min) | 15 | $1,725 | $115 |
2016: 7 services
| New patient visit (30+ min) | 84 | $5,410 | $64 |
| Short return visit (20+ min) | 89 | $4,962 | $38 |
| Diagnostic exam of nasal passages using an endoscope | 58 | $3,966 | $51 |
| Diagnostic exam of voice box using a flexible endoscope | 51 | $3,241 | $62 |
| Return visit (30+ min) | 23 | $1,611 | $70 |
| New patient visit (45+ min) | 14 | $1,177 | $84 |
| Removal of impacted ear wax | 13 | $337 | $24 |
2015: 7 services
| Short return visit (20+ min) | 139 | $8,738 | $42 |
| New patient visit (30+ min) | 114 | $7,389 | $65 |
| Diagnostic exam of voice box using a flexible endoscope | 74 | $5,668 | $68 |
| Diagnostic exam of nasal passages using an endoscope | 69 | $4,550 | $56 |
| New patient visit (45+ min) | 34 | $3,226 | $95 |
| Removal of impacted ear wax | 11 | $366 | $28 |
| Exam of ear using a microscope | 17 | $190 | $8 |
2014: 8 services
| New patient visit (30+ min) | 140 | $8,572 | $61 |
| Short return visit (20+ min) | 116 | $6,689 | $43 |
| Diagnostic exam of voice box using a flexible endoscope | 82 | $5,905 | $68 |
| New patient visit (45+ min) | 45 | $4,292 | $95 |
| Diagnostic exam of nasal passages using an endoscope | 46 | $2,871 | $54 |
| Removal of impacted ear wax | 29 | $872 | $28 |
| Return visit (30+ min) | 13 | $739 | $57 |
| Exam of ear using a microscope | 13 | $155 | $8 |
2013: 6 services
| New patient visit (45+ min) | 29 | $3,264 | $113 |
| Diagnostic exam of voice box using a flexible endoscope | 24 | $1,862 | $67 |
| New patient visit (30+ min) | 25 | $1,582 | $63 |
| Short return visit (20+ min) | 24 | $1,314 | $44 |
| Diagnostic exam of nasal passages using an endoscope | 13 | $781 | $56 |
| Removal of impacted ear wax | 17 | $450 | $25 |
Medicaid work
$1,321 in 2024
Medicaid paid $1,321 for 36 billed services this clinician did in 2024, up to 12 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Nasal endoscopy, diagnostic, unilateral or bilateral (separate procedure) | 24 | $888 |
| Service | 12 | $434 |
| 2024 | 36 | 2 | 12 | $1,321 |
| 2023 | 26 | 2 | 14 | $1,288 |
| 2022 | 13 | 1 | 13 | $519 |
| 2021 | 24 | 2 | 12 | $765 |
| 2020 | 14 | 1 | 14 | $376 |
| 2019 | 12 | 1 | 12 | $161 |
| 2018 | 28 | 2 | 15 | $1,375 |
See the largest Medicaid services in earlier years
2023
| New patient visit (30+ min) | 14 | $872 |
| Nasal endoscopy, diagnostic, unilateral or bilateral (separate procedure) | 12 | $417 |
2022
| Service | 13 | $519 |
2021
| Service | 12 | $435 |
| Nasal endoscopy, diagnostic, unilateral or bilateral (separate procedure) | 12 | $330 |
2020
| Short return visit (20+ min) | 14 | $376 |
2019
| Short return visit (20+ min) | 12 | $161 |
2018
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 15 | $1,010 |
| Short return visit (20+ min) | 13 | $366 |
Drugs they prescribed that Part D paid
$40,666
Pharmacies billed $40,666 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 7% of their Part D prescriptions (11 of 169) in 2024. Above the middle of the specialty; the typical otolaryngology clinician is at 4%.
157 generic and 12 brand-name prescriptions · $40,666 in drug cost · 13 antibiotic prescriptions to 12 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ipratropium | 61 | $1,499 | $25 |
| Ofloxacin | 15 | $612 | $41 |
| Azelastine | 11 | $305 | $28 |
| Hydrocodone-Acetaminophen | 11 | $96 | $9 |
Year by year
| 2024 | 169 | 78 | 7% (11) | 7% | $40,666 |
| 2023 | 173 | 71 | None | None | $5,518 |
| 2022 | 142 | 64 | None | 15% | $28,191 |
| 2021 | 109 | 48 | None | 19% | $47,608 |
| 2020 | 122 | 56 | 9% (11) | None | $24,796 |
| 2019 | 152 | 57 | None | None | $6,176 |
| 2018 | 131 | 54 | 9% (12) | None | $8,199 |
| 2017 | 91 | 52 | None | None | $3,006 |
| 2016 | 172 | 74 | 11% (18) | 8% | $5,456 |
| 2015 | 333 | 121 | 7% (24) | 7% | $16,336 |
| 2014 | 248 | 105 | 5% (12) | 12% | $11,960 |
| 2013 | 59 | 37 | None | None | $2,362 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Ofloxacin | 22 | $1,611 | $73 |
| Ipratropium | 57 | $1,600 | $28 |
| Mupirocin | 27 | $270 | $10 |
2022: 4 drugs
| Omnaris | 11 | $6,935 | $630 |
| Ofloxacin | 11 | $627 | $57 |
| Ipratropium | 15 | $584 | $39 |
| Fluticasone Propionate | 17 | $156 | $9 |
2021: 3 drugs
| Dupixent | 14 | $43,714 | $3,122 |
| Ipratropium | 21 | $888 | $42 |
| Fluticasone Propionate | 11 | $131 | $12 |
2020: 3 drugs
| Ipratropium | 20 | $495 | $25 |
| Ofloxacin | 14 | $398 | $28 |
| Hydrocodone-Acetaminophen | 11 | $45 | $4 |
2019: 3 drugs
| Ipratropium | 34 | $1,782 | $52 |
| Ofloxacin | 12 | $1,005 | $84 |
| Hydrochlorothiazide | 15 | $28 | $2 |
2018: 2 drugs
| Ipratropium | 49 | $3,670 | $75 |
| Ofloxacin | 19 | $2,993 | $158 |
2017: 2 drugs
| Ipratropium | 22 | $894 | $41 |
| Fluticasone Propionate | 12 | $211 | $18 |
2016: 5 drugs
| Ipratropium | 26 | $758 | $29 |
| Fluticasone Propionate | 27 | $383 | $14 |
| Ranitidine | 21 | $321 | $15 |
| Hydrocodone-Acetaminophen | 18 | $218 | $12 |
| Prednisone | 11 | $89 | $8 |
2015: 8 drugs
| Ranitidine | 28 | $1,421 | $51 |
| Nystatin | 14 | $907 | $65 |
| Ipratropium | 36 | $889 | $25 |
| Fluticasone Propionate | 52 | $884 | $17 |
| Omeprazole | 23 | $854 | $37 |
| Clotrimazole | 13 | $445 | $34 |
| Hydrocodone-Acetaminophen | 20 | $285 | $14 |
| Prednisone | 19 | $207 | $11 |
2014: 5 drugs
| Fluticasone Propionate | 35 | $1,075 | $31 |
| Omeprazole | 28 | $865 | $31 |
| Amox Tr-Potassium Clavulanate | 21 | $513 | $24 |
| Ranitidine | 19 | $257 | $14 |
| Prednisone | 17 | $171 | $10 |
Money from drug and device companies
$2,000 in 2021
| 2021 | 1 | 1 | $2,000 | $2,000 |
| 2019 | 1 | 1 | None | $111 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Acclarent | Acclarent Balloon Inflation Device | $2,000 | 1 payment
|
See the published payment
| Acclarent | Consulting · 2021-04-27 | Acclarent Balloon Inflation Device | $2,000 |
See earlier years (2019)
2019: $111
| Teva Pharmaceuticals USA | Austedo | $111 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1467612739
- Licence
- CA A125587California A125587: Current · expires 2028-07-31
- Trained
- Albert Einstein College of Medicine of Yeshiva University, 2008
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Otolaryngology (207Y00000X)
- Mailing address
- 300 Pasteur Dr, Palo Alto, CA, 94304
- NPI first listed
- 2008-06-11
- NPI last updated
- 2024-04-29
- NPI record certified
- 2024-04-29
This is when the NPI record was last certified, not a medical board exam.